Fetal death of unspecified cause

P16_FETAL_DEATH_UNSP_CAUSE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P95 Cause of death: ICD-10 — P95 2 out of 7 registries used, show all original rules.	60
4. Check minimum number of events None	60
5. Include endpoints None	60
6. Filter based on genotype QC (FinnGen only)	60

Control definitions (FinnGen only)

Control exclude: P16_OTH_DISORD_ORIGINA_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P9
Name in latin: Mors fetus causa non specificata

NAME	P16_FETAL_DEATH_UNSP_CAUSE
CONTROL_EXCLUDE	P16_OTH_DISORD_ORIGINA_PERINA_PERIOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P95
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P95
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Fetal death of unspecified cause based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	391	384	-
Only index persons	380	378	-
Unadjusted period prevalence (%)
Whole population	0.01	0.01	-
Only index persons	0.01	0.01	-
Median age at first event (years)
Whole population	31.05	31.27	-
Only index persons	31.20	31.27	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	60	60	-
Unadjusted period prevalence (%)	0.02	0.02	-
Median age at first event (years)	31.78	31.78	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
60: Matched controls
600

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P95

ICD-10 Finland

Fetal death of unspecified cause

+∞

86.1

G02CB01

ATC

bromocriptine; systemic

31.8

19.0

O36.4

ICD-10 Finland

Maternal care for intrauterine death

77.3

15.7

Z39.2

ICD-10 Finland

Routine postpartum follow-up

8.1

15.0

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

6.7

12.0

MBA03

NOMESCO Finland

Curettage of uterus after delivery or abortion

17.7

11.0

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

11.7

8.7

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

5.42

2.46

17.8

5.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.51

2.44

1.6

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

289

2.15

2.03

3.8

3.4

—

17.40

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

4.85

1.98

2.0

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

4.85

1.98

2.0

1.2

—

(3042936) Bacteria identified in Isolate by Culture

2.42

1.62

3.3

2.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3.53

1.55

3.0

3.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3.06

1.55

20.8

4.0

1.27

1.89

mmol/l

—

(3012544) pH of Venous blood

3.06

1.55

5.3

3.0

—

(4035726) Immunohistochemistry procedure

2.60

1.53

1.1

1.2

—

(3013512) EKG study

2.03

1.51

4.1

2.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2.78

1.40

1.2

1.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.78

1.40

2.5

1.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

2.66

1.34

2.0

2.4

—

(3000991) Gas panel - Venous blood

2.93

1.31

27.8

4.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.55

1.28

2.5

1.8

—

(3002032) Base excess in Venous blood by calculation

2.63

1.17

5.6

2.5

1.16

1.49

mmol/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.09

1.14

2.6

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

198

1.66

1.07

2.4

2.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

327

1.67

1.02

4.0

3.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

2.35

0.96

20.3

4.8

104.83

105.22

mmol/l

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.99

0.92

3.3

3.9

4.38

4.73

pmol/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

115

1.67

0.89

3.4

1.2

2.40

2.15

g/l

0.15

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1.85

0.89

3.3

2.7

9.00

155.11

ng/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

504

2.09

0.87

3.5

3.4

1.50

1.57

mmol/l

0.77

484

(3003694) ABO and Rh group [Type] in Blood

135

0.53

0.86

3.0

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

162

1.57

0.83

5.1

4.2

37.91

36.81

g/l

0.64

157

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.91

0.81

18.8

4.9

239.67

237.73

u/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

127

1.60

0.80

2.1

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.66

0.78

2.3

3.3

—

(3023368) Bacteria identified in Blood by Culture

1.70

0.75

6.6

3.4

—

(3044889) 12 lead EKG panel

320

0.67

0.75

4.2

2.5

—

(3021589) Normoblasts [#/volume] in Blood

207

0.63

0.75

20.4

7.6

0.00

e9/l

0.48

172

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

506

2.04

0.74

3.8

3.5

2.98

3.01

mmol/l

0.09

484

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

112

1.58

0.73

1.8

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

461

1.71

0.71

3.8

3.7

—

(3003338) MCHC [Mass/volume]

477

1.67

0.63

16.3

12.1

331.25

331.67

g/l

0.12

477

(1002224) Polysomnography panel

1.73

0.63

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1.73

0.63

2.4

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1.62

0.62

1.4

1.6

1672.00

1068.20

nmol/l

—

(3035941) MCH [Entitic mass]

580

+∞

0.61

24.9

14.6

29.69

30.11

0.91

575

(3026361) Erythrocytes [#/volume] in Blood

580

+∞

0.61

25.0

14.6

4.51

4.47

e12/l

0.40

571

(3010813) Leukocytes [#/volume] in Blood

580

+∞

0.61

25.0

14.7

6.38

6.53

e9/l

0.31

568

(3000963) Hemoglobin [Mass/volume] in Blood

581

+∞

0.61

25.2

14.7

132.73

134.11

g/l

0.38

575

(3024731) MCV [Entitic volume]

579

+∞

0.61

24.9

14.6

89.47

90.48

1.08

574

(3019225) pH of Specimen

1.85

0.61

2.3

5.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

483

1.57

0.52

4.6

4.9

1.67

4.06

mu/l

0.50

463

(3041096) Erythrocytes [Presence] in Urine by Automated

148

1.42

0.52

2.8

2.3

—

(40758558) Short blood count panel - Blood

129

0.64

0.50

20.9

6.8

—

(40768804) Tissue Pathology biopsy report

223

0.72

0.47

2.3

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.45

0.47

2.4

1.3

—

(21494755) Public health laboratory ask at order entry panel

1.47

0.46

1.5

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.41

0.43

2.0

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

122

0.69

0.40

2.8

1.8

114.56

119.59

u/l

—

116

(3023323) Follitropin [Units/volume] in Serum or Plasma

1.36

0.39

1.0

1.3

33.51

28.16

iu/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

238

0.76

0.38

15.0

6.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

414

1.35

0.38

4.1

4.4

13.53

14.13

pmol/l

0.97

399

(3026008) Bacteria identified in Urine by Culture

109

1.37

0.38

1.9

2.2

—

(3017732) Neutrophils [#/volume] in Blood

1.48

0.37

4.7

2.0

2.59

4.07

e9/l

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

395

1.31

0.35

3.9

2.6

30.16

34.53

u/l

0.51

387

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

129

1.33

0.35

3.5

2.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.37

0.35

1.8

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

284

1.27

0.34

3.8

2.8

61.98

60.79

ug/l

0.04

269

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.34

0.34

4.7

3.2

32.00

30.53

—

(3022217) INR in Platelet poor plasma by Coagulation assay

139

1.31

0.34

8.8

8.9

0.98

1.02

inr

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.40

0.32

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

107

0.71

0.32

1.3

1.8

—

(36660697) Celiac disease serology panel - Serum

1.36

0.32

1.1

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

482

1.39

0.31

3.6

3.1

1.21

1.24

mmol/l

0.11

458

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

210

1.24

0.28

3.3

2.3

76.62

73.72

nmol/l

0.16

198

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

241

1.22

0.26

6.8

6.0

11.57

9.51

umol/l

0.57

231

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.34

0.24

1.4

1.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

425

1.24

0.22

4.7

3.9

37.33

37.29

mmol/mol

0.01

411

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

4.3

—

4.62

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

4.6

—

58.64

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

0.21

0.0

2.1

—

5.02

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.21

0.0

2.6

—

(3010421) pH of Blood

0.00

0.21

0.0

2.1

—

7.45

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

0.21

0.0

2.1

—

10.19

—

(3020891) Body temperature

0.00

0.21

0.0

5.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.31

0.21

5.8

2.0

2.43

2.55

g/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.20

0.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.20

0.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

119

1.23

0.20

4.9

2.7

32.82

12.99

ng/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.21

0.19

2.1

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

207

1.18

0.19

3.7

2.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

129

0.82

0.16

1.4

1.5

1.09

1.53

mmol/l

2.43

115

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

514

1.27

0.16

20.5

10.0

17.23

16.79

mg/l

0.05

381

(3013115) Eosinophils [#/volume] in Blood

261

0.87

0.15

14.0

6.0

0.12

0.18

e9/l

2.99

245

(3044640) Blood type and Crossmatch panel - Blood

132

1.18

0.15

3.5

2.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

108

0.80

0.14

2.9

1.8

4.03

2.79

mg/l

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

192

1.14

0.13

15.0

5.0

1.21

1.22

mmol/l

0.19

166

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

155

0.87

0.10

2.4

1.6

86.72

100.80

pmol/l

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.07

0.09

1.2

1.4

—

(3000494) Fungus identified in Specimen by Culture

1.15

0.09

2.7

1.2

—

(3022145) Colonoscopy Study observation

1.12

0.09

1.5

1.4

—

(3002256) Pathology report gross observation

0.78

0.08

1.6

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

1.15

0.08

5.2

2.3

7.25

7.83

mmol/l

0.14

(40768797) Stomach Pathology biopsy report

1.05

0.08

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

0.85

0.07

1.3

1.5

483.86

459.47

pmol/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

0.85

0.07

4.4

2.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

161

0.91

0.06

4.4

3.3

2.36

2.34

mmol/l

0.41

150

(3001604) Monocytes [#/volume] in Blood

251

0.93

0.05

13.1

5.8

0.50

0.53

e9/l

0.30

231

(3006315) Basophils [#/volume] in Blood

251

0.93

0.05

13.1

5.8

0.03

0.04

e9/l

0.37

230

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

170

0.92

0.04

1.7

1.4

—

(3018010) Neutrophils/100 leukocytes in Blood

240

1.07

0.04

12.6

5.4

53.84

56.40

0.58

229

(3022096) Basophils/100 leukocytes in Blood

229

0.94

0.03

14.6

5.6

0.55

0.66

0.48

215

(1761868) Lipid panel - Serum or Plasma

239

0.94

0.03

2.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

172

1.07

0.02

14.2

4.2

1.21

1.22

mmol/l

0.16

161

(3002030) Lymphocytes/100 leukocytes in Blood

243

1.05

0.01

13.0

5.5

33.63

29.92

1.16

233

(3019550) Sodium [Moles/volume] in Serum or Plasma

484

1.07

0.01

22.0

8.6

139.57

139.79

mmol/l

0.24

472

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

144

1.06

0.01

6.2

2.3

48.53

54.09

u/l

0.30

138

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.01

0.00

1.4

1.7

—

(36304419) Bacteria [Presence] in Urine

1.04

0.00

4.5

2.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

487

1.03

0.00

22.8

8.7

3.85

3.90

mmol/l

0.58

474

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

125

1.05

0.00

1.4

1.3

3.58

7.02

u/ml

—

(3006504) Eosinophils/100 leukocytes in Blood

235

0.97

0.00

14.1

5.5

2.16

2.78

1.45

224

(3019069) Monocytes/100 leukocytes in Blood

234

0.97

0.00

14.2

5.8

8.65

8.04

0.31

223

(3019198) Lymphocytes [#/volume] in Blood

262

0.99

0.00

12.3

5.8

1.91

1.92

e9/l

0.02

246

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

152

0.98

0.00

1.8

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.88

0.00

1.7

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.01

-0.00

2.1

1.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.93

-0.00

3.0

1.3

1.38

1.23

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

-0.00

0.0

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.6

—

7.41

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

-0.00

0.0

6.7

—

1.31

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

10.0

—

0.71

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

100.80

—

(1616796) Gas panel - Central venous blood

0.00

-0.00

0.0

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.90

-0.00

1.6

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.5

—

58.83

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.5

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

15.7

—

1645.71

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

51.80

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

9.84

—

(3022806) Fractional oxyhemoglobin in Capillary blood

0.00

-0.00

0.0

1.5

—

90.77

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

14.4

—

946.86

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3000492) Spirometry study

0.98

-0.00

1.2

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.93

-0.00

3.2

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

0.00

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

-0.00

0.0

8.2

—

3.76

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

4.3

—

40.17

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

-0.00

0.0

1.0

—

0.00

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

7.93

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

-0.00

0.0

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.03

-0.00

1.2

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_FETAL_DEATH_UNSP_CAUSE and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_FETAL_DEATH_UNSP_CAUSE.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_FETAL_DEATH_UNSP_CAUSE – Fetal death of unspecified cause

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Fetal death of unspecified cause

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints